𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Double-Blinded Randomized Study of High-Dose Calcitriol Plus Docetaxel Compared With Placebo Plus Docetaxel in Androgen-Independent Prostate Cancer: A Report From the ASCENT Investigators

✍ Scribed by Kibel, A.S.

Book ID
122840472
Publisher
Elsevier Science
Year
2008
Weight
55 KB
Volume
2008
Category
Article
ISSN
0084-4071

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Double-blinded randomized study of high-
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: A report from the ASCENT investigators: Beer TM, Ryan CW, Venner PM, Petrylak DP, Chatta GS, Ruether JD, Redfern CH, Fehrenbacher L, Saleh MN, Waterhouse DM, Carducci MA, Vicario D, Dreicer R, Higano CS, Ahmann FR, Chi KN, Henner WD, Arroyo A, Clow FW, ASCENT Investigators, Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health and Science University, Portland, OR
✍ Donald L. Trump πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 42 KB
Intermittent chemotherapy in patients wi
Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer : Results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel
✍ Tomasz M. Beer; Christopher W. Ryan; Peter M. Venner; Daniel P. Petrylak; Gurkam πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Survival in patients with metastatic, chemotherapy‐naive, androgen‐independent prostate cancer (AIPC) is improved with 10 to 12 cycles of docetaxel‐containing chemotherapy but further management is undefined. In the current study, the authors examined retreatment with th

Intermittent chemotherapy in patients wi
Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: Results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel: Beer TM, Ryan CW, Venner PM, Petrylak DP, Chatta GS, Ruether JD, Chi KN, Young J, Henner WD, ASCENT (AIPC Study of Calcitriol Enhancing Taxotere) Investigators, Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR
✍ Donald L. Trump πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 42 KB